These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 37732210)
1. The structure of a Hargett AA; Azurmendi HF; Crawford CJ; Wear MP; Oscarson S; Casadevall A; Freedberg DI bioRxiv; 2023 Sep; ():. PubMed ID: 37732210 [No Abstract] [Full Text] [Related]
2. The structure of a Hargett AA; Azurmendi HF; Crawford CJ; Wear MP; Oscarson S; Casadevall A; Freedberg DI Proc Natl Acad Sci U S A; 2024 Feb; 121(7):e2315733121. PubMed ID: 38330012 [No Abstract] [Full Text] [Related]
3. A Paracoccidioides brasiliensis glycan shares serologic and functional properties with cryptococcal glucuronoxylomannan. Albuquerque PC; Cordero RJ; Fonseca FL; Peres da Silva R; Ramos CL; Miranda KR; Casadevall A; Puccia R; Nosanchuk JD; Nimrichter L; Guimaraes AJ; Rodrigues ML Fungal Genet Biol; 2012 Nov; 49(11):943-54. PubMed ID: 23010152 [TBL] [Abstract][Full Text] [Related]
4. Capsule structural heterogeneity and antigenic variation in Cryptococcus neoformans. McFadden DC; Fries BC; Wang F; Casadevall A Eukaryot Cell; 2007 Aug; 6(8):1464-73. PubMed ID: 17601878 [TBL] [Abstract][Full Text] [Related]
5. Structural studies of the capsular polysaccharide of a non-neoformans Cryptococcus species identified as C. laurentii, which was reclassified as Cryptococcus flavescens, from a patient with AIDS. Ikeda R; Maeda T Carbohydr Res; 2004 Feb; 339(3):503-9. PubMed ID: 15013387 [TBL] [Abstract][Full Text] [Related]
9. A Glucuronoxylomannan Epitope Exhibits Serotype-Specific Accessibility and Redistributes towards the Capsule Surface during Titanization of the Fungal Pathogen Cryptococcus neoformans. Probert M; Zhou X; Goodall M; Johnston SA; Bielska E; Ballou ER; May RC Infect Immun; 2019 Apr; 87(4):. PubMed ID: 30670549 [TBL] [Abstract][Full Text] [Related]
11. Contribution of the mannan backbone of cryptococcal glucuronoxylomannan and a glycolytic enzyme of Staphylococcus aureus to contact-mediated killing of Cryptococcus neoformans. Ikeda R; Saito F; Matsuo M; Kurokawa K; Sekimizu K; Yamaguchi M; Kawamoto S J Bacteriol; 2007 Jul; 189(13):4815-26. PubMed ID: 17483230 [TBL] [Abstract][Full Text] [Related]
12. Analysis of human monoclonal antibodies elicited by vaccination with a Cryptococcus neoformans glucuronoxylomannan capsular polysaccharide vaccine. Pirofski L; Lui R; DeShaw M; Kressel AB; Zhong Z Infect Immun; 1995 Aug; 63(8):3005-14. PubMed ID: 7622223 [TBL] [Abstract][Full Text] [Related]
15. Antigenic and biological characteristics of mutant strains of Cryptococcus neoformans lacking capsular O acetylation or xylosyl side chains. Kozel TR; Levitz SM; Dromer F; Gates MA; Thorkildson P; Janbon G Infect Immun; 2003 May; 71(5):2868-75. PubMed ID: 12704160 [TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibodies specific for immunorecessive epitopes of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans, reduce serotype bias in an immunoassay for cryptococcal antigen. Percival A; Thorkildson P; Kozel TR Clin Vaccine Immunol; 2011 Aug; 18(8):1292-6. PubMed ID: 21697342 [TBL] [Abstract][Full Text] [Related]
17. A cryptococcal capsular polysaccharide mimotope prolongs the survival of mice with Cryptococcus neoformans infection. Fleuridor R; Lees A; Pirofski L J Immunol; 2001 Jan; 166(2):1087-96. PubMed ID: 11145689 [TBL] [Abstract][Full Text] [Related]
18. Structure of the O-deacetylated glucuronoxylomannan from Cryptococcus neoformans serotype C as determined by 2D 1H NMR spectroscopy. Bacon BE; Cherniak R Carbohydr Res; 1995 Oct; 276(2):365-86. PubMed ID: 8542606 [TBL] [Abstract][Full Text] [Related]
19. Antibodies elicited by a Cryptococcus neoformans-tetanus toxoid conjugate vaccine have the same specificity as those elicited in infection. Casadevall A; Mukherjee J; Devi SJ; Schneerson R; Robbins JB; Scharff MD J Infect Dis; 1992 Jun; 165(6):1086-93. PubMed ID: 1583327 [TBL] [Abstract][Full Text] [Related]